Veronica Miller, PhD

Associate Research Professor, Prevention and Community Health; GWU SPHHS
Associate Research Professor, Epidemiology and Biostatistics, GWU SPHHS
Associate Research Professor, Health Policy, GWU SPHHS
Director, Forum for Collaborative HIV Research

Phone: (202) 530-2311
Fax: (202) 530-3923
Email: vmiller@gwu.edu
Website: http://www.gwumc.edu/sphhs/faculty/miller_veronica.cfm

Current HIV/AIDS Educational Activities:

• PubH 388 - Approaches to HIV Prevention: "An Interdisciplinary Overview"
• PubH 209.21 Issues in HIV Care & Treatment

Current HIV/AIDS Research Activities:

• Director, Forum for Collaborative HIV Research (www.hivforum.org)

Current HIV/AIDS Service Activities:

• HIV Research Discussion Group – a "brown bag" informal seminar series bringing together non-laboratory based HIV Research at GWU and organizations in the DC area
• CME lecture series for the GWU and greater DC communities
• Workshop on Quantitative Methods for Research on Antiviral Drug Resistance (annual workshop sponsored jointly by the Forum for Collaborative HIV Research and Harvard University)
• Various industry and government advisory committees
• Various conference and workshop organizing committees
• Frequent reviewer for AIDS, JAIDS, JID, CID and other journals

Veronica Miller is Associate Research Professor and Director of the Forum for Collaborative HIV Research in the Department of Prevention and Community Health at The George Washington University School of Public Health and Health Services.

Professor Miller's intellectual journey has taken her from JW Goethe University in Frankfurt, Germany, where she directed an interdisciplinary HIV clinical research program, to GW, where she oversees a group that helps to shape the HIV research agenda for the future. "Early on, we recognized the need to learn from each patient and set of patients participating in clinical studies," she says, which led her to help establish the Frankfurt HIV cohort. Studies of that population have generated important data about treatment effectiveness and viral drug resistance, and influenced regulatory policy in Europe and North America. With knowledge evolving rapidly, Professor Miller also co-founded and chaired the EuroGuidelines Group in 1998 to create uniform standard-of-care guidelines across the continent.

In becoming Director of the Forum for Collaborative HIV Research, which works to advance clinical research and translate results into patient care, Professor Miller has emphasized the importance of involving all stakeholders in driving the field of HIV treatment forward. Under her leadership, the Forum has expanded to include a focus on prevention research, policy discussions and broadened the scope from domestic to the global HIV epidemic. In addition to her academic appointment in the Department of Prevention and Community Health, Professor Miller holds secondary appointments in the Departments of Epidemiology & Biostatistics and of Health Policy

Professor Miller has published extensively on HIV treatment strategies, especially on the immunological and virological impact of antiretroviral drug protocols. A key area of interest is viral drug resistance and the characterization of treatment failure.

Community Service

Professor Miller serves on numerous industry and government advisory boards, including the NIH FY07 Office of AIDS Research Planning Workshop for HIV/AIDS Research, the NIH's Special Emphasis Panel focused on enrolling women and minority populations in clinical trials of microbicides and HIV vaccines, the Bill & Melinda Gates Grand Challenges in Health Technical Review Panel, and the FDA Division of Antiretroviral Drugs Advisory Committee.